Abstract: American Journal of HematologyVolume 24, Issue 4 p. 441-455 Concise Review Nutrition and sickle cell disease John David Reed, John David Reed Department of Medicine and the Comprehensive Sickle Cell Program, The School of Medicine, The University of North Carolina at Chapel HillSearch for more papers by this authorRupa Redding-Lallinger, Rupa Redding-Lallinger Department of Medicine and the Comprehensive Sickle Cell Program, The School of Medicine, The University of North Carolina at Chapel HillSearch for more papers by this authorEugene P. Orringer M. D., Corresponding Author Eugene P. Orringer M. D. Department of Medicine and the Comprehensive Sickle Cell Program, The School of Medicine, The University of North Carolina at Chapel HillDivision of Hematology, Department of Medicine, 340 MacNider Building (202H), UNC School of Medicine, Chapel Hill, N. C. 27514Search for more papers by this author John David Reed, John David Reed Department of Medicine and the Comprehensive Sickle Cell Program, The School of Medicine, The University of North Carolina at Chapel HillSearch for more papers by this authorRupa Redding-Lallinger, Rupa Redding-Lallinger Department of Medicine and the Comprehensive Sickle Cell Program, The School of Medicine, The University of North Carolina at Chapel HillSearch for more papers by this authorEugene P. Orringer M. D., Corresponding Author Eugene P. Orringer M. D. Department of Medicine and the Comprehensive Sickle Cell Program, The School of Medicine, The University of North Carolina at Chapel HillDivision of Hematology, Department of Medicine, 340 MacNider Building (202H), UNC School of Medicine, Chapel Hill, N. C. 27514Search for more papers by this author First published: April 1987 https://doi.org/10.1002/ajh.2830240416Citations: 43AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Scott RB, Ferguson AD, Jenkins ME, Clark HM: Studies in sickle-cell anemia. VIII. Further observations on the clinical manifestations of sickle-cell anemia in children. Am J Dis Child 90: 682–91, 1955. 2 Natta C, Machlin L: Plasma levels of tocopherol in sickle cell anemia subjects. Am J Clin Nutr 32: 1359–1362, 1979. 3 Odonkor PO, Addae SK, Yamamoto S, Aputu RS: Effect of dietary nitrogen on urinary excretion of non-protein nitrogen in adolescent sickle cell patients. Hum Nutr Clin Nutr 38C: 23–29, 1984. 4 Heyman MB, Katz R, Hurst D, Chiu D, Ammann AJ, Vichinsky E, Gaffield B, Castillo R, Kleman K, Thaler MM, Lubin B: Growth retardation in sickle-cell disease treated by nutritional support. Lancet 1: 903–906, 1985. 5 Alperin JB: Folic acid deficiency complicating sickle cell anemia: A study on the response to titrated doses of folic acid. Arch Intern Med 120: 298–306, 1967. 6 Rahbar F, Scott RB, Jily P: Studies in sickle cell anemia: Preliminary observation on gastrointestinal digestion and absorption. J Natl Med Assoc 69: 103–1004, 1977. 7 Walker BR, Alexander F: Uric acid excretion in sickle cell anemia. JAMA 215: 255–258, 1971. 8 Diamond HS, Meisel AD, Holden D: The natural history of urate overproduction in sickle cell anemia. Ann Intern Med 90: 752–757, 1979. 9 De Ceulaer K, Morgan AG, Choo-Kang E, Wilson WA, Serjeant GR: Serum urate concentrations in homozygous sickle cell disease. J Clin Pathol 34: 965–969, 1981. 10 Diamond H, Sharon E, Holden D, Cacatian A: Renal handling of uric acid in sickle cell anemia. Adv Exp Med Biol 41B: 759–762, 1974. 11 Odonkor PO, Yamamoto S, Addae SK: Nitrogen balance in adolescent sickle cell patients. IRCS Med Sci 10: 303, 1982. 12 Bensinger TA, Gillette PN: Hemolysis in sickle cell disease. Arch Intern Med 133: 624–631, 1974. 13 Odonkor PO, Addae SK, Apatu RS, Yamamoto S: Basal metabolic rate and serum thyroid hormone levels in adolescent sickle cell patients. IRCS Med Sci 10: 891, 1982. 14 Root AW: Endocrinology of puberty. II. Aberrations of sexual maturation. J Pediatr 83: 197–200, 1973. 15 Whitten CF: Growth status of children with sickle cell anemia. Am J Dis Child 102: 355–364, 1961. 16 Ashcroft MT, Serjeant GR, Desai P: Heights, weights, and skeletal age of Jamaican adolescents with sickle cell anaemia. Arch Dis Child 47: 519–524, 1972. 17 Serjeant GR, Ashcroft MT: Delayed skeletal maturation in sickle cell anemia in Jamaica. Johns Hopkins Med J 132: 95–101, 1973. 18 Olambiwonnu NO, Penny R, Frasier SD: Sexual maturation in subjects with sickle cell anemia: Studies of serum gonadotropin concentration, height, weight, and skeletal age. J Pediatr 87: 459–464, 1975. 19 McCormack MK, Dicker L, Katz SH, Caleb M, McDaniels J, Humphery A, Buchert E, Lubin B: Growth patterns of children with sickle-cell disease. Hum Biol 48: 429–437, 1976. 20 Luban NLC, Leikin SL, August GA: Growth and development in sickle cell anemia: Preliminary report. Am J Pediatr Hematol Oncol 4: 61–65, 1982. 21 Phebus CK, Gloninger MF, Maciak BJ: Growth patterns by age and sex in children with sickle cell disease. J Pediatr 105: 28–33, 1984. 22 Platt RS, Rosenstock W, Espeland MA: Influence of sickle hemoglobinopathies on growth and development. N Engl J Med 311: 7–12, 1984. 23 Winsor R, Burch GE: The habitus of patients with sickle cell anemia. Hum Biol 16: 99–114, 1944. 24 Sharp EA, Von der Heide EC: Eunuchoid habitus associated with sickle-cell anemia and the sickling trait. J Clin Endocrinol Metab 4: 505–520, 1944. 25 Winsor T, Burch GE: Habitus of patients with active sickle cell anemia of long duration. Arch Intern Med 76: 47–53, 1945. 26 Margolies MP: Sickle cell anemia, composite study and survey. Medicine 30: 357–443, 1951. 27 Hook EW, Cooper GR: The clinical manifestations of sickle cell - hemoglobin C disease and sickle cell anemia. South Med J 51: 610–626, 1958. 28 Booker CR, Scott RB, Ferguson AD: Studies in sickle cell anemia XXII: Clinical manifestations of sickle cell anemia during the first two years of life. Clin Pediatr 3: 111–115, 1964. 29 Jimenez CT, Scott RB, Henry WL, Sampson CC, Ferguson AD: Studies in sickle cell anemia XXVI: The effects of homozygous sickle cell disease on the onset of menarche, pregnancy, fertility, pubescent changes, and body growth in Negro subjects. Am J Dis Child 111: 497–504, 1966. 30 Gross S, Godel J: Comparative studies of height and weight as a blood volume reference standard in normal children and children with sickle cell anemia. Am J Clin Pathol 55: 662–670, 1971. 31 Ashcroft MT, Serjeant GR: Body habitus of Jamaican adults with sickle cell anemia. South Med J 65: 579–582, 1972. 32 Lowry MF, Desai P, Ashcroft MT, Serjeant BE, Serjeant GR: Heights and weights of Jamaican children with homozygous sickle cell disease. Hum Biol 49: 429–436, 1977. 33 Abbasi AA, Prasad AS, Ortega J, Congco E, Oberleas D: Gonadal function abnormalities in sickle cell anemia: Studies in adult male patients. Ann Intern Med 85: 601–605, 1976. 34 Kramer MS, Rooks Y, Washington LA, Pearson HA: Pre- and postnatal growth and development in sickle cell anemia. J Pediatr 96: 857–860, 1980. 35 Odonkor PO, Addae SK, Yamamoto S: Growth hormone secretion in sickle cell patients. IRCS Med Sci 11: 108–109, 1983. 36 Russell MO, Finan A, Moskowitz SR, Elmer MA, Gill FM: Nutrition and poor growth in preadolescent children with sickling disorders. Pediatr Res 15: 586, 1981. 37 O'Brien RT, McIntosh S, Aspnes GT, Pearson HA: Prospective study of sickle cell anemia in infancy. J Pediatr 89: 205–210, 1976. 38 Serjeant GR, Grandison Y, Lowrie Y, Mason K. Phillips J, Serjeant BE, Vaidya S: The development of haematological changes in homozygous sickle cell disease: A cohort study from birth to 6 years. Br J Haematol 48: 533–543, 1981. 39 Serjeant GR, Richards R, Barbor PRH, Milner PF: Relatively benign sickle-cell anaemia in 60 patients aged over 30 in the West Indies. Br Med J 3: 86–91, 1968. 40 Edelman R: Cell-mediated immune response in protein calorie malnutrition–A review. In RM Suskind (ed): “ Malnutrition and the Immune Response”. New York: Raven, 1977, p 47. 41 Chandra RK, Newberne PM: Immunocompetence in undernutrition. In “ Nutrition, Immunity, and Infection: Mechanisms of Interactions”. New York: Plenum, 1977, p 67. 42 Axelrod AE: Nutrition in relation to immunity. In ME Shils, RS Goodhart (eds): “ Modern Nutrition in Health and Disease”. Philadelphia: Lea & Febiger, 1980, p 578. 43 Glassman AB, Deas DV, Berlinsky FS, Bennett CE: Lymphocyte blast transformation and peripheral lymphocyte percentages in patients with sickle cell disease. Ann Clin Lab Sci 10: 9–12, 1980. 44 Hernandez P, Cruz C, Santos MN, Ballester JM: Immunologic dysfunction in sickle cell anemia. Acta Haematol 63: 156–161, 1980. 45 Mankad VN, Ronnlund RD, Suskind RM. Increased immune function in sickle cell disease patients after zine therapy. Pediatr Res 17: 237a, 1982. 46 Vichinsky E, Heyman M, Hurst D, Chiu D, Gaffield B, Thompson K, Kleman K, Lubin B: Nutrition in sickle cell anemia (HB SS), Pediatr Res 18: 251a, 1984. 47 Ballester OF, Abdallah JM, Prasad AS: Lymphocyte subpopulation abnormalities in sickle cell anemia. Am J Hematol 21: 23, 1986. 48 Chandra RK: Immunoglobulin and antibody response in protein-calorie malnutrition–A review. In RM Suskind (ed): “ Malnutrition and the Immune Response”. New York: Raven, 1977. p 155. 49 Frisch RE, Revelle R: Height and weight at menarche and a hypothesis of critical body weights and adolescent events. Science 169: 397–399, 1970. 50 Frisch RE: Weight at menarche: Similarity for well nourished and undernourished girls at differing ages and evidence for historical constancy. Pediatrics 50: 445–450, 1972. 51 Frisch RE: A method of prediction of age of menarche from height and weight at ages 9 through 13 years. Pediatries 53: 384–390, 1974. 52 Alleyne II, Rauseo RD, Serjeant GR: Sexual development and fertility of Jamaican female patients with homozygous sickle cell disease, Arch Intern Med 141: 1295–1297, 1981. 53 Lubin B, Krauss R, Kleman K, Simmons E, Chiu D: Reduced total serum cholesterol (TC), high density (HDL) and low density (LDL) lipoproteins in patients with sickle cell anemia (SCA). Blood 54: 30a, 1979. 54 Muskiet FD, Muskiet FAJ: Lipids, fatty acids and trace elements in plasma and erythrocytes of pediatric patients with homozygous sickle cell disease. Clin Chim Acta 142: 1–10, 1984. 55 Maclver JR, Went LM: Sickle cell anaemia complicated by megaloblastic anaemia of infancy. Br Med J 1: 775–779, 1960. 56 Shaldon S: Megaloblastic erythropoiesis associated with sickle cell anemia. Br Med J 1: 640–641, 1961. 57 Jonsson V, Roath OS, Kirkpatrick CL: Nutritional megaloblastic anemia associated with sickle cell states. Blood 15: 535–547, 1959. 58 Zuelzer WW, Rutzky J: Megaloblastic anemia of infancy. Adv Pediatr 6: 283–306, 1953. 59 Watson-Williams EJ: Folic acid deficiency in sickle cell disease. East Afr Med J 39: 213–221, 1962. 60 Lindenbaum J, Klipstein FA: Folic acid deficiency in sickle-cell anemia. N Engl J Med 269: 875–882, 1963. 61 Pierce LE, Rath CE: Evidence for folic acid deficiency in the genesis of anemic sickle cell crisis. Blood 20: 19–32, 1962. 62 Pearson HA, Cobb WT: Folic acid studies in sickle-cell anemia. J Lab Clin Med 64: 913–921, 1964. 63 MV Krause, LK Mahan (eds.): “ Food, Nutrition and Diet Therapy”, 7th edition. Philadelphia: Saunders, 1984, p 597. 64 Liu YK: Folic acid deficiency in sickle cell anemia. Scand J Haematol 14: 71–79, 1975. 65 Rabb LM, Grandison Y, Mason K, Hayes RJ, Serjeant B, Serjeant GR: A trial of folate supplementation in children with homozygous sickle cell disease. Br J Haematol 54: 589–594, 1983. 66 Solomon LR: Considerations in the use of B6 vitamers in hematologic disorders: I. Red cell transport and metabolism of pyridoxal. Blood 59: 495–501, 1982. 67 Kark JA, Hannah JS, Kale MP, Hicks CU, Bongiovanni R: Modification of intracellular hemoglobin by vitamin B 6. Blood 54: 55a, 1979. 68 Zaugg RH, Walder JA, Klotz IM: Schiff base adducts of hemoglobin: Modifications that inhibit erythrocyte sickling. J Biol Chem 252: 8542–8548, 1977. 69 Kark JA, Tarassoff PG, Bongiovanni R, Hicks CU, Jenkins E: Pyridoxal phosphate as an antisickling agent in vitro. J Clin Invest 71: 1224–1229, 1983. 70 Kark JA, Kale MP, Tarassoff PG, Woods M, Lessin LS: Inhibition of erythrocyte sickling in vitro by pyridoxal. J Clin Invest 71: 1224–1229, 1983. 71 Kuranstin-Mills J, Lessin LS: Rheological assessment of antisickling effects of pyridoxine and pyridoxal. Blood Cells 8: 315–328, 1982. 72 Natta CL, Reynolds RD: Apparent vitamin B6 deficiency in sickle cell anemia. Am J Clin Nutr 40: 235–239, 1984. 73 Osifo BOA, Adeyokunnu A, Parmentier Y, Gerard P, Nicolas JP: Abnormalities of serum transcobalamins in sickle cell disease (HbSS) in Black Africa. Scand J Haematol 30: 135–140, 1983. 74 Osifo BOA, Lukanmbi FA, Adeyokunnu A: Serum cobalamin concentration in sickle cell disease. Acta Haematol 71: 299–303, 1984. 75 Varma RN, Mankad VN, Phelps DD, Jenkins LD, Suskind RM: Depressed erythrocyte glutathione reductase activity in sickle cell disease. Am J Clin Nutr 38: 884–887, 1983. 76 Tappel AL, Brown WD, Zalkin H, Maier VP: Unsaturated lipid peroxidation catalyzed by hematin compounds and its inhibition by vitamin E. J Am Oil Chem Soc 38: 5, 1961. 77 Melhorn DK, Gross S, Lake GA, Leu JA: The hydrogen peroxide fragility test and serum tocopherol level in anemias of various etiologies. Blood 37: 438–446, 1971. 78 Chiu D, Lubin B: Abnormal vitamin E and glutathione peroxidase levels in sickle cell anemia: Evidence for increased susceptibility to lipid peroxidation in vivo. J Lab Clin Med 94: 542–548, 1979. 79 Zimmerman CP, Natta C: Glutathione peroxidase activity in whole blood of patients with sickle cell anemia. Scand J Haematol 26: 177–181, 1981. 80 Nair CR, McCullough MS, Das SK: Red cell membrane peroxidation and superoxide dismutase. Fed Proc 36: 1067, 1977. 81 Serjeant GR, Serjeant BE, Milner PF: The irreversibly sickled cell: A determinant of haemolysis in sickle cell anemia. Br J Haematol 17: 527–533, 1969. 82 Hebbel RP, Eaton JW, Balasingam M, Steinberg MH: Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest 70: 1253–1259, 1982. 83 Bowie LJ, Carreathers SA, Wright AG: Lipid membrane peroxidation, vitamin E, and the generation of irreversibly sickled cells in sickle cell anemia. Clin Chem 25: 1076, 1979. 84 Das SK, Nair RC: Superoxide dismutase, glutathione peroxidase, catalase, and lipid peroxidation of normal and sickled erythrocytes. Br J Haematol 44: 87–92, 1980. 85 Lux SE, John KM, Karnovsky MJ: Irreversible deformation of the spectrin-actin lattice in irreversibly sickled cells. J Clin Invest 58: 955–963, 1976. 86 Palek J, Liu SC: Dependence of spectrin organization in red blood cell membranes on cell metabolism: Implications for control of red cell shape, deformability, and surface area. Semin Hematol 16: 75–93, 1979. 87 Mohandas N, Chasis JA, Shohet SB: The influence of membrane skeleton on red cell deformability, membrane material properties, and shape. Semin Hematol 20: 225–242, 1983. 88 Chiu D, Lubin B, Shohet SB: Erythrocyte membrane lipid reorganization during the sickling process. Br J Haematol 41: 223–234, 1979. 89 Oski FA, Barness LA: A previously unrecognized cause of hemolytic anemia in the premature infant. J Pediatr 70: 211–220, 1967. 90 Leonard PJ, Losowsky MS: Effect of alpha-tocopherol administration on red cell survival in vitamin E-deficient human subjects. Am J Clin Nutr 24: 388–393, 1971. 91 Farrell PM, Bieri JG, Frantantoni JF, Wood RE, di Sant' Agnese PA: The occurrence and effects of human vitamin E deficiency: A study in patients with cystic fibrosis. J Clin Invest 60: 233–241, 1977. 92 Chiu D, Vichinsky E, Yee M, Kleman K, Lubin B: Peroxidation, vitamin E, and sickle-cell anemia. Ann NY Acad Sci 82: 323–335, 1982. 93 Natta CL, Machlin LJ, Brin M: A decrease in irreversibly sickled erythrocytes in sickle cell anemia patients given vitamin E. Am J Clin Nutr 33: 968–971, 1980. 94 Clark MR, Mohandas N, Embury SH, Lubin BH: A simple laboratory alternative to irreversibly sickled cell (ISC) counts. Blood 60: 659–662, 1981. 95 Prasad AS, Schoomaker EB, Ortega J, Brewer GJ, Oberleas D, Oelshlegel FJ: Zinc deficiency in sickle cell disease. Clin Chem 21: 582–587, 1975. 96 Serjeant GR, Galloway RE, Gueri MC: Oral zinc sulphate in sickle-cell ulcers. Lancet 2: 891–893, 1970. 97 Karayalcin G, Rosner F, Kim KY, Chandra P: Plasma-zinc in sickle cell anaemia. Lancet 1: 217, 1974. 98 Prasad AS, Schoomaker EB, Ortega J, Brewer GJ, Oberleas D, Oelshlegel: Deficiency of zinc in sickle cell disease patients. In JT Hercules, AN Schechter, WA Eaton, RE Jackson (eds): “ Proceedings of the First National Symposium on Sickle Cell Disease”. Bethesda: DHEW, 1974, p 33. 99 Prasad AS, Ortega J, Brewer GJ, Oberleas D, Schoomaker EB: Trace elements in sickle cell disease. JAMA 235: 2396–2398, 1976. 100 Karayalcin G, Lanzkowsky P, Kazi AB: Zinc deficiency in children with sickle cell disease. Am J Pediatr Hematol Oncol 1: 283–284, 1979. 101 Prasad AS, Rabbani P, Warth JA: Effect of zinc on hyperammonemia in sickle cell anemia subjects. Am J Hematol 7: 323–327, 1979. 102 Prasad AS, Cossack ZT: Neutrophil zinc: An indicator of zinc status in man. Trans Assoc Am Physicians 95: 165–176, 1982. 103 Carpentieri U, Smith L, Daeschner CW, Haggard ME: Neutrophils and zinc in infection-prone children with sickle cell disease. Pediatrics 72: 88–92, 1983. 104 Tapazoglou E, Prasad AS, Hill G, Brewer GJ, Kaplan J: Decreased natural killer cell activity in patients with zinc deficiency with sickle cell disease. J Lab Clin Med 105: 19–22, 1985. 105 Prasad AS, Fernandez-Madrid F, Ryan JR: Deoxythymidine kinase activity of human implanted sponge connective tissue in zinc deficiency. Am J Physiol 236: E272–E275, 1979. 106 Prasad AS, Cossack ZT: Zinc supplementation and growth in sickle cell disease. Ann Intern Med 100: 367–371, 1984. 107 Prasad AS, Abbasi AA, Rabbani P, DuMouchelle E: Effect of zinc supplementation on serum testosterone level in adult male sickle cell anemia subjects. Am J Hematol 10: 119–127, 1981. 108 Warth JA, Prasad AS, Zwas F, Frank RN: Abnormal dark adaptation in sickle cell anemia. J Lab Clin Med 98: 189–194, 1981. 109 Ballester OF, Prasad AS: Anergy, zinc deficiency, and decreased nucleoside phosphorylase activity in patients with sickle cell anemia. Ann Intern Med 98: 180–182, 1983. 110 Daeschner CW, Matusik MC, Carpentieri U, Haggard ME: Zinc and growth in patients with sickle cell disease. J Pediatr 98: 778–780, 1981. 111 Niell HB, Leach BE, Kraus AP: Zinc metabolism in sickle cell anemia. JAMA 242: 2686–2687, 1979. 112 Matustik MC, Chausmer AB, Meyer WJ: The effect of sodium intake on zinc excretion in patients with sickle cell anemia. J Am Coll Nutr 1: 331–336, 1982. 113 Guenther JM, Brewer GJ, Vander AJ, Prasad AS: Zinc deficiency in sickle cell anemia: Renal defects in handling zinc. Clin Res 32: 148A, 1984. 114 Butler LC, Taylor ML, McCurdy PR, Mahmood L: Zinc status in adult sickle cell anemia patients. Fed Am Soc Exp Biol 36: 1139, 1977. 115 Kapu MM, Fleming AF, Ezem BU: Plasma-zinc in sickle-cell anaemia. Lancet 1: 920, 1976. 116 Daeschner CW, Carpentieri U, Goldman AS, Haggard ME: Zinc deficiency and blood lymphocyte function with sickle cell disease. Scand J Haematol 35: 186–190, 1985. 117 Barrett-Connor E: Bacterial infection and sickle cell anemia: An analysis of 250 infections in 166 patients and a review of the literature. Medicine 50: 97–112, 1971. 118 Brewer GJ, Oelshlegel FJ: Antisickling effects of zinc. Biochem Biophys Res Commun 58: 854–861, 1974. 119 Oelshlegel FJ, Prasad AS, Brewer GJ, Oberleas D, Knutsen C, Schoornaker EB: Zinc and sicklecell disease. J Clin Invest 52: 62a, 1973. 120 Brewer GJ, Brewer LF, Prasad AS: Suppression of irreversibly sickled erythrocytes by zinc therapy in sickle cell anemia. J Lab Clin Med 90: 549–554, 1977. 121 Rao NJ, Sur AM: Iron deficiency in sickle cell disease. Acta Paediatr Scand 69: 963–968, 1981 122 Okechealain TC, Obi GO: Iron deficiency in sickle cell anemia in Nigerian children. Ann Trop Paediatr 2: 89–92, 1982. 123 Powars DR: Natural history of sickle cell disease-the first ten years. Semin Hematol 12: 267, 1975 124 Vichinsky E, Kleman K, Embury S, Lubin B: The diagnosis of iron deficiency anemia in sickle cell disease. Blood 58: 963–968, 1981. 125 Serjeant GR, Mason K, Serjeant BE, Sewell A, Vaidya S: Haematological indices in normal Negro children: A Jamaican cohort from birth to five years. Clin Lab Haematol 2: 169–178, 1980. 126 Anderson GN: The iron status of pregnant women with hemoglobinopathies. Am J Obstet Gynecol 113: 895–900, 1972. 127 Roopnarinesingh S: Iron stores in pregnant patients with anemia and hemoglobin S. Br J Obstet Gynecol 83: 375–377, 1976. 128 Oluboyede OA: Iron studies in pregnant and non-pregnant women with hemoglobin SS or SC disease. Br J Obstet Gynecol 87: 989–996, 1980. 129 Peterson CM, Graziano JH, de Cuitiis A, Grady RW, Cerami A, Worwood M, Jacobs A: Iron metabolism, sickle cell disease and response to cyanate. Blood 46: 383, 1975. 130 Haddy TB, Castro O: Overt iron deficiency in sickle cell disease. Arch Intern Med 142: 1621, 1982. 131 Usanga EA, Oluboyede OA: Iron status of children with and without sickle cell anemia. Niger J Paediatr 10: 7–11, 1983. 132 Castro O, Haddy TB: Improved survival of iron deficient patients with sickle erythrocytes. N Engl J Med 308: 527, 1983. 133 Rao KRP et al: Iron deficiency and sickle cell anemia. Arch Intern Med 143: 1030–1032, 1983. 134 Erlandson ME et al: Studies on congenital hemolytic syndromes. IV. Gastrointestinal absorption of iron. Blood 19: 359, 1962. 135 Green TW, Conley CL, Berthrong M: The liver in sickle cell anemia. Johns Hopkins Med Bull 92: 99, 1953. 136 Rosenblate HJ, Eisensteino R, Holmes AW: The liver in sickle cell anemia: A clinical-pathologic study. Arch Pathol 90: 235, 1970. 137 Mahoney BS, Ambruso DR, Githens HJ: Iron studies in sickle cell anemia. J Pediatr 92: 1070, 1978. 138 Cohen A, Schwartz E: Iron chelation therapy in sickle cell anemia. Am J Hematol 7: 69–76. 1979. 139 O'Brien, RT: Iron burden in sickle cell anemia. J Pediatr 92: 579, 1978. 140 Kapu MM, Fleming AF, Ezem BU: Plasma-copper in sickle-cell anemia. Lancet 2: 153, 1976. 141 Behera SK, Satpathy KN, Patnaik BK, Panda C, Das D: Serum copper in sickle cell disease. Indian Pediatr 18: 395–399, 1981. 142 Schaeffer K, Aikens J, Williamson M, Olson EJ: The distribution of copper in sickling erythrocytes as determined by an IBM cell separator. J Natl Med Assoc 73: 653–656, 1981. 143 Brewer GJ, Hill GM, Dick RD, Prasad AS, Cossack ZT: Interactions of trace elements: Clinical significance. J Am Coll Nutr 4: 33–38, 1985. Citing Literature Volume24, Issue4April 1987Pages 441-455 ReferencesRelatedInformation
Publication Year: 1987
Publication Date: 1987-04-01
Language: en
Type: review
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 73
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot